4/25
08:01 am
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Medium
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
4/25
06:39 am
sage
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress [Yahoo! Finance]
Low
Report
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress [Yahoo! Finance]
4/25
06:30 am
sage
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Low
Report
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
4/24
10:53 am
sage
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
4/24
07:10 am
sage
Registration for Association of Bioscience Financial Officers 2024 National Conference in May in Boston Nearing Full Capacity [Yahoo! Finance]
Neutral
Report
Registration for Association of Bioscience Financial Officers 2024 National Conference in May in Boston Nearing Full Capacity [Yahoo! Finance]
4/23
07:48 pm
sage
Ex-Stanford President's AI Drug Startup Pulls In $1 Billion in Commitments [BNN Bloomberg (Canada)]
Medium
Report
Ex-Stanford President's AI Drug Startup Pulls In $1 Billion in Commitments [BNN Bloomberg (Canada)]
4/19
11:01 pm
sage
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
4/18
01:52 pm
sage
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal [Yahoo! Finance]
Low
Report
Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal [Yahoo! Finance]
4/25/2024
06:30 am
sage
sage therapeutics, inc.
MISS
Report
1.4%
sage therapeutics, inc.
2/14/2024
06:30 am
sage
sage therapeutics, inc.
BEAT
Report
6.5%
sage therapeutics, inc.
11/7/2023
06:30 am
sage
sage therapeutics, inc.
MISS
Report
-4.8%
sage therapeutics, inc.
5/2/2023
06:30 am
sage
sage therapeutics, inc.
BEAT
Report
-7.9%
sage therapeutics, inc.
4/25
07:16 am
sage
Form 10-Q Sage Therapeutics, Inc. For: Mar 31
Low
Report
Form 10-Q Sage Therapeutics, Inc. For: Mar 31
4/25
06:46 am
sage
Form 8-K Sage Therapeutics, Inc. For: Apr 25
Low
Report
Form 8-K Sage Therapeutics, Inc. For: Apr 25
4/24
04:14 pm
sage
Form ARS Sage Therapeutics, Inc. For: Dec 31
Medium
Report
Form ARS Sage Therapeutics, Inc. For: Dec 31
4/24
04:11 pm
sage
Form DEFA14A Sage Therapeutics, Inc.
Medium
Report
Form DEFA14A Sage Therapeutics, Inc.
4/24
04:08 pm
sage
Form DEF 14A Sage Therapeutics, Inc. For: Jun 10
Medium
Report
Form DEF 14A Sage Therapeutics, Inc. For: Jun 10
4/19
08:32 am
sage
Form 8-K Sage Therapeutics, Inc. For: Apr 16
Medium
Report
Form 8-K Sage Therapeutics, Inc. For: Apr 16
4/17
06:36 am
sage
Form 8-K Sage Therapeutics, Inc. For: Apr 17
High
Report
Form 8-K Sage Therapeutics, Inc. For: Apr 17
3/27
04:10 pm
sage
Form SC TO-I/A Sage Therapeutics, Inc. Filed by: Sage Therapeutics, Inc.
Low
Report
Form SC TO-I/A Sage Therapeutics, Inc. Filed by: Sage Therapeutics, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register